Global Achalasia Treatment Production, Demand and Key Producers, 2022-2028

December 2022 | 97 pages | ID: GC46210106C4EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Achalasia is a rare disorder that makes it difficult for food and liquid to pass from the swallowing tube connecting your mouth and stomach (esophagus) into your stomach. Achalasia occurs when nerves in the esophagus become damaged.

This report studies the global Achalasia Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Achalasia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Achalasia Treatment that contribute to its increasing demand across many markets.

The global Achalasia Treatment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Achalasia Treatment total market, 2017-2028, (USD Million)

Global Achalasia Treatment total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Achalasia Treatment total market, key domestic companies and share, (USD Million)

Global Achalasia Treatment revenue by player and market share 2017-2022, (USD Million)

Global Achalasia Treatment total market by Type, CAGR, 2017-2028, (USD Million)

Global Achalasia Treatment total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Achalasia Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd and Ohio State Medical Center, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Achalasia Treatment market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Achalasia Treatment Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Achalasia Treatment Market, Segmentation by Type
  • Calcium Channel Blockers (CCBs)
  • Nifedipine
  • Botulinum Toxin Injection
  • Others
Global Achalasia Treatment Market, Segmentation by Application
  • Hospitals
  • Retail Pharmacy
  • Online Pharmacy
Companies Profiled:
  • Bausch Health US LLC
  • Pfizer
  • Accordhealthcare
  • AdvaCare Pharma
  • Merz Therapeutics
  • Galderma
  • Zydus Pharmaceuticals (USA) Inc
  • Teva pharmaceutical industries ltd
  • Ohio State Medical Center
Key Questions Answered

1. How big is the global Achalasia Treatment market?

2. What is the demand of the global Achalasia Treatment market?

3. What is the year over year growth of the global Achalasia Treatment market?

4. What is the total value of the global Achalasia Treatment market?

5. Who are the major players in the global Achalasia Treatment market?

6. What are the growth factors driving the market demand?
'@LOT1 SUPPLY SUMMARY

1.1 Achalasia Treatment Introduction
1.2 World Achalasia Treatment Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Achalasia Treatment Total Market by Region
  1.3.1 World Achalasia Treatment Market Size by Region (2017-2028)
  1.3.2 United States Achalasia Treatment Market Size (2017-2028)
  1.3.3 China Achalasia Treatment Market Size (2017-2028)
  1.3.4 Europe Achalasia Treatment Market Size (2017-2028)
  1.3.5 Japan Achalasia Treatment Market Size (2017-2028)
  1.3.6 South Korea Achalasia Treatment Market Size (2017-2028)
  1.3.7 ASEAN Achalasia Treatment Market Size (2017-2028)
  1.3.8 India Achalasia Treatment Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Achalasia Treatment Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Achalasia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD ACHALASIA TREATMENT COMPANIES COMPETITIVE ANALYSIS

2.1 World Achalasia Treatment Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Achalasia Treatment Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Achalasia Treatment in 2021
  2.2.3 Global Concentration Ratios (CR8) for Achalasia Treatment in 2021
2.3 Achalasia Treatment Company Evaluation Quadrant
2.4 Achalasia Treatment Market: Overall Company Footprint Analysis
  2.4.1 Achalasia Treatment Market: Region Footprint
  2.4.2 Achalasia Treatment Market: Company Product Type Footprint
  2.4.3 Achalasia Treatment Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Achalasia Treatment Market Comparison
  3.1.1 United States VS China: Achalasia Treatment Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Achalasia Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Achalasia Treatment Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Achalasia Treatment in United States, Headquarters (States, Country)
  3.2.2 United States Achalasia Treatment Revenue by Domestic Player, (2017-2022)
3.3 China Achalasia Treatment Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Achalasia Treatment in China, Headquarters (Province, Country)
  3.3.2 China Achalasia Treatment Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Achalasia Treatment Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Achalasia Treatment in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Achalasia Treatment Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Achalasia Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Calcium Channel Blockers (CCBs)
  4.2.2 Nifedipine
  4.2.3 Botulinum Toxin Injection
  4.2.4 Others
4.3 Market Segment by Type
  4.3.1 World Achalasia Treatment Market Size by Type (2017-2022)
  4.3.2 World Achalasia Treatment Market Size by Type (2023-2028)
  4.3.3 World Achalasia Treatment Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Achalasia Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospitals
  5.2.2 Retail Pharmacy
  5.2.3 Online Pharmacy
5.3 Market Segment by Application
  5.3.1 World Achalasia Treatment Market Size by Application (2017-2022)
  5.3.2 World Achalasia Treatment Market Size by Application (2023-2028)
  5.3.3 World Achalasia Treatment Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Bausch Health US LLC
  6.1.1 Bausch Health US LLC Details
  6.1.2 Bausch Health US LLC Major Business
  6.1.3 Bausch Health US LLC Achalasia Treatment Product and Services
  6.1.4 Bausch Health US LLC Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Bausch Health US LLC Recent Developments/Updates
  6.1.6 Bausch Health US LLC Competitive Strengths & Weaknesses
6.2 Pfizer
  6.2.1 Pfizer Details
  6.2.2 Pfizer Major Business
  6.2.3 Pfizer Achalasia Treatment Product and Services
  6.2.4 Pfizer Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Pfizer Recent Developments/Updates
  6.2.6 Pfizer Competitive Strengths & Weaknesses
6.3 Accordhealthcare
  6.3.1 Accordhealthcare Details
  6.3.2 Accordhealthcare Major Business
  6.3.3 Accordhealthcare Achalasia Treatment Product and Services
  6.3.4 Accordhealthcare Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Accordhealthcare Recent Developments/Updates
  6.3.6 Accordhealthcare Competitive Strengths & Weaknesses
6.4 AdvaCare Pharma
  6.4.1 AdvaCare Pharma Details
  6.4.2 AdvaCare Pharma Major Business
  6.4.3 AdvaCare Pharma Achalasia Treatment Product and Services
  6.4.4 AdvaCare Pharma Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 AdvaCare Pharma Recent Developments/Updates
  6.4.6 AdvaCare Pharma Competitive Strengths & Weaknesses
6.5 Merz Therapeutics
  6.5.1 Merz Therapeutics Details
  6.5.2 Merz Therapeutics Major Business
  6.5.3 Merz Therapeutics Achalasia Treatment Product and Services
  6.5.4 Merz Therapeutics Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Merz Therapeutics Recent Developments/Updates
  6.5.6 Merz Therapeutics Competitive Strengths & Weaknesses
6.6 Galderma
  6.6.1 Galderma Details
  6.6.2 Galderma Major Business
  6.6.3 Galderma Achalasia Treatment Product and Services
  6.6.4 Galderma Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Galderma Recent Developments/Updates
  6.6.6 Galderma Competitive Strengths & Weaknesses
6.7 Zydus Pharmaceuticals (USA) Inc
  6.7.1 Zydus Pharmaceuticals (USA) Inc Details
  6.7.2 Zydus Pharmaceuticals (USA) Inc Major Business
  6.7.3 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Product and Services
  6.7.4 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Zydus Pharmaceuticals (USA) Inc Recent Developments/Updates
  6.7.6 Zydus Pharmaceuticals (USA) Inc Competitive Strengths & Weaknesses
6.8 Teva pharmaceutical industries ltd
  6.8.1 Teva pharmaceutical industries ltd Details
  6.8.2 Teva pharmaceutical industries ltd Major Business
  6.8.3 Teva pharmaceutical industries ltd Achalasia Treatment Product and Services
  6.8.4 Teva pharmaceutical industries ltd Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Teva pharmaceutical industries ltd Recent Developments/Updates
  6.8.6 Teva pharmaceutical industries ltd Competitive Strengths & Weaknesses
6.9 Ohio State Medical Center
  6.9.1 Ohio State Medical Center Details
  6.9.2 Ohio State Medical Center Major Business
  6.9.3 Ohio State Medical Center Achalasia Treatment Product and Services
  6.9.4 Ohio State Medical Center Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Ohio State Medical Center Recent Developments/Updates
  6.9.6 Ohio State Medical Center Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Achalasia Treatment and Key Manufacturers
7.2 Achalasia Treatment Manufacturing Costs
7.3 Achalasia Treatment Production Process
7.4 Achalasia Treatment Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Achalasia Treatment Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Achalasia Treatment Typical Distributors
8.3 Achalasia Treatment Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Achalasia Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Achalasia Treatment Market Size by Region (2017-2022) & (USD Million)
Table 3. World Achalasia Treatment Market Size by Region (2023-2028) & (USD Million)
Table 4. World Achalasia Treatment Market Size Market Share by Region (2017-2022)
Table 5. World Achalasia Treatment Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Achalasia Treatment Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Achalasia Treatment Players in 2021
Table 9. World Achalasia Treatment Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Achalasia Treatment Company Evaluation Quadrant
Table 11. Head Office of Key Achalasia Treatment Player
Table 12. Achalasia Treatment Market: Company Product Type Footprint
Table 13. Achalasia Treatment Market: Company Product Application Footprint
Table 14. Achalasia Treatment Mergers & Acquisitions Activity
Table 15. United States VS China Achalasia Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Achalasia Treatment in United States, Headquarters (States, Country)
Table 17. United States Achalasia Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Achalasia Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Achalasia Treatment in China, Company Headquarters (Province, Country)
Table 20. China Achalasia Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Achalasia Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Achalasia Treatment in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Achalasia Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Achalasia Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Achalasia Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Achalasia Treatment Revenue by Type (2017-2022) & (USD Million)
Table 27. World Achalasia Treatment Revenue by Type (2023-2028) & (USD Million)
Table 28. World Achalasia Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Achalasia Treatment Revenue by Application (2017-2022) & (USD Million)
Table 30. World Achalasia Treatment Revenue by Application (2023-2028) & (USD Million)
Table 31. Bausch Health US LLC Basic Information, Area Served and Competitors
Table 32. Bausch Health US LLC Major Business
Table 33. Bausch Health US LLC Achalasia Treatment Product and Services
Table 34. Bausch Health US LLC Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bausch Health US LLC Recent Developments/Updates
Table 36. Bausch Health US LLC Competitive Strengths & Weaknesses
Table 37. Pfizer Basic Information, Area Served and Competitors
Table 38. Pfizer Major Business
Table 39. Pfizer Achalasia Treatment Product and Services
Table 40. Pfizer Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Pfizer Recent Developments/Updates
Table 42. Pfizer Competitive Strengths & Weaknesses
Table 43. Accordhealthcare Basic Information, Area Served and Competitors
Table 44. Accordhealthcare Major Business
Table 45. Accordhealthcare Achalasia Treatment Product and Services
Table 46. Accordhealthcare Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Accordhealthcare Recent Developments/Updates
Table 48. Accordhealthcare Competitive Strengths & Weaknesses
Table 49. AdvaCare Pharma Basic Information, Area Served and Competitors
Table 50. AdvaCare Pharma Major Business
Table 51. AdvaCare Pharma Achalasia Treatment Product and Services
Table 52. AdvaCare Pharma Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. AdvaCare Pharma Recent Developments/Updates
Table 54. AdvaCare Pharma Competitive Strengths & Weaknesses
Table 55. Merz Therapeutics Basic Information, Area Served and Competitors
Table 56. Merz Therapeutics Major Business
Table 57. Merz Therapeutics Achalasia Treatment Product and Services
Table 58. Merz Therapeutics Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Merz Therapeutics Recent Developments/Updates
Table 60. Merz Therapeutics Competitive Strengths & Weaknesses
Table 61. Galderma Basic Information, Area Served and Competitors
Table 62. Galderma Major Business
Table 63. Galderma Achalasia Treatment Product and Services
Table 64. Galderma Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Galderma Recent Developments/Updates
Table 66. Galderma Competitive Strengths & Weaknesses
Table 67. Zydus Pharmaceuticals (USA) Inc Basic Information, Area Served and Competitors
Table 68. Zydus Pharmaceuticals (USA) Inc Major Business
Table 69. Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Product and Services
Table 70. Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Zydus Pharmaceuticals (USA) Inc Recent Developments/Updates
Table 72. Zydus Pharmaceuticals (USA) Inc Competitive Strengths & Weaknesses
Table 73. Teva pharmaceutical industries ltd Basic Information, Area Served and Competitors
Table 74. Teva pharmaceutical industries ltd Major Business
Table 75. Teva pharmaceutical industries ltd Achalasia Treatment Product and Services
Table 76. Teva pharmaceutical industries ltd Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Teva pharmaceutical industries ltd Recent Developments/Updates
Table 78. Ohio State Medical Center Basic Information, Area Served and Competitors
Table 79. Ohio State Medical Center Major Business
Table 80. Ohio State Medical Center Achalasia Treatment Product and Services
Table 81. Ohio State Medical Center Achalasia Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 82. Achalasia Treatment Raw Material
Table 83. Key Manufacturers of Achalasia Treatment Raw Materials
Table 84. Achalasia Treatment Typical Distributors
Table 85. Achalasia Treatment Typical Customers

LIST OF FIGURES

Figure 1. Achalasia Treatment Picture
Figure 2. World Achalasia Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Achalasia Treatment Total Market Size (2017-2028) & (USD Million)
Figure 4. World Achalasia Treatment Market Size Market Share by Region (2017-2028)
Figure 5. United States Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 6. China Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 7. Europe Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 8. Japan Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 11. India Achalasia Treatment Market Size (2017-2028) & (USD Million)
Figure 12. Achalasia Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Achalasia Treatment by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Achalasia Treatment Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Achalasia Treatment Markets in 2021
Figure 17. United States VS China: Achalasia Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Achalasia Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Achalasia Treatment Market Size Market Share by Type in 2021
Figure 20. Calcium Channel Blockers (CCBs)
Figure 21. Nifedipine
Figure 22. Botulinum Toxin Injection
Figure 23. Others
Figure 24. World Achalasia Treatment Market Size Market Share by Type (2017-2028)
Figure 25. World Achalasia Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Achalasia Treatment Market Size Market Share by Application in 2021
Figure 27. Hospitals
Figure 28. Retail Pharmacy
Figure 29. Online Pharmacy
Figure 30. World Achalasia Treatment Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Achalasia Treatment in 2021
Figure 32. Manufacturing Process Analysis of Achalasia Treatment
Figure 33. Achalasia Treatment Industrial Chain
Figure 34. Distribution Channel Breakdown for Achalasia Treatment Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source


More Publications